NRC HEALTH NRC
Nasdaq · XNAS · stock · Services-Commercial Physical & Biological Research · website · IPO 1997-10-01
NRC HEALTH insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Berwick Donald M | director | 2026-06-23 | Grant | 7,697 | — |
| Bhandari Parul | director | 2026-06-23 | Grant | 7,697 | — |
| Lockhart Stephen H | director | 2026-06-23 | Grant | 7,697 | — |
| NUNNELLY JOHN N | director | 2026-06-23 | Grant | 7,697 | — |
| Wheeler Penny Ann | director | 2026-06-23 | Grant | 7,697 | — |
| Rau Jason Russell | Executive Vice President | 2026-03-12 | Grant | 60,000 | — |
| HARRISON SHANE R | EVP & Chief Financial Officer | 2026-02-17 | Buy | 8,000 | $12.27 |
| HARRISON SHANE R | EVP & Chief Financial Officer | 2025-12-29 | Tax withheld | 21,271 | $18.66 |
Source: SEC EDGAR filings · CIK 0000070487 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.